|
Novartis to Boost China Presence
The Swiss drug maker said it plans to buy a majority stake in Chinese vaccines maker Zhejiang Tianyuan for around $125 million, as it seeks to boost its presence in the world's third-largest vaccines market. Rating :
 (No ratings) |
 |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.34